66 results
8-K
EX-99.1
CRVS
Corvus Pharmaceuticals, Inc.
19 Mar 24
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:02pm
, 2023) reported from the trial in December 2023 in conjunction with the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, one
8-K
EX-99.1
CRVS
Corvus Pharmaceuticals, Inc.
7 Nov 23
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
4:03pm
, will be presented in a poster presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in December 2023.
Soquelitinib
8-K
EX-99.1
0mn8 eojh9
6 Sep 23
Other Events
7:39pm
8-K
EX-99.1
h6fnswjgxzyg7
3 Nov 22
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:06pm
8-K
EX-99.1
y1kfc3si2x9ocumqh2k
8 Aug 22
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
4:05pm
424B5
3uecm 4ct
2 Nov 21
Prospectus supplement for primary offering
6:05am
8-K
EX-99.1
spjodv42y
1 Nov 21
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
4:07pm